Compared to controls, MDSC depletion led to an increase in the frequency of activated CD3 CD107a T effector cells (Figure 2F) and systemic splenic T cell specific cytolysis against CFSE labeled parental tumor [E:T at 10∶1, (1.5–2 fold) and at 5∶1, (2 fold)] (Figure 2G). This evidence concerns the gene LAMP1 and neoplasm.